Not applicableStudy completedNCT04326023What this trial is testingMyelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)Who this might be right forCancer University Hospital, Caen 178
Testing effectiveness (Phase 2)Looking for participantsNCT07148180What this trial is testingA Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and VenetoclaxWho this might be right forAcute Myeloid Leukaemia (AML)LeukemiaBlood Cancer+1 more Jacqueline Garcia, MD 31
Large-scale testing (Phase 3)Ended earlyNCT01339910What this trial is testingReduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)Who this might be right forLeukemia, Myelocytic, Acute Medical College of Wisconsin 272
Early research (Phase 1)UnknownNCT04365179What this trial is testingStudy of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AMLWho this might be right forAdvanced MDSAML Immune System Key Ltd 18
Early research (Phase 1)Looking for participantsNCT03630991What this trial is testingEdetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing ChemotherapyWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+15 more M.D. Anderson Cancer Center 58
Early research (Phase 1)Study completedNCT02892318What this trial is testingA Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Hoffmann-La Roche 40
Early research (Phase 1)Ended earlyNCT02676323What this trial is testingPanobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome St. Jude Children's Research Hospital 19
Early research (Phase 1)Study completedNCT00004862What this trial is testingAugmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01238211What this trial is testingCombination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more National Cancer Institute (NCI) 61
Early research (Phase 1)Study completedNCT00087204What this trial is testingRebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+13 more National Cancer Institute (NCI) 40
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06532084What this trial is testingSorafenib Relapase Prophylaxis After HCT With PTBCy RegimenWho this might be right forAcute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more St. Petersburg State Pavlov Medical University 88
Testing effectiveness (Phase 2)Study completedNCT04269213What this trial is testingCPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years OldWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesSecondary Acute Myeloid Leukemia+1 more Roswell Park Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00739388What this trial is testingAzacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyWho this might be right forLeukemia Swiss Cancer Institute 47
Early research (Phase 1)Looking for participantsNCT06690827What this trial is testingClinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCNWho this might be right forAML (Acute Myeloid Leukemia)BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04093570What this trial is testingParticipants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)Who this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes Taiho Oncology, Inc. 332
Testing effectiveness (Phase 2)Study completedNCT05115630What this trial is testingOff-the-shelf NK Cells + SCT for Myeloid MalignanciesWho this might be right forMyeloid MalignanciesAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07754799What this trial is testingTrial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Institute of Hematology & Blood Diseases Hospital, China 320
Not applicableStudy completedNCT04644419What this trial is testingChemotherapy-related Cognitive Impairment and Acute LeukemiaWho this might be right forAcute Myeloid Leukemia UNC Lineberger Comprehensive Cancer Center 25
Not applicableUnknownNCT01329471What this trial is testingFunctional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Hillel Yaffe Medical Center 75